FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029128861> ?p ?o ?g. }

• W3029128861 endingPage "574" @default.
• W3029128861 startingPage "571" @default.
• W3029128861 abstract "ObjectiveTo investigate the optimal regimen of narrow-band ultraviolet B (NB-UVB) phototherapy in the treatment of chronic actinic dermatitis (CAD) , and to analyze factors influencing treatment compliance.MethodsDemographic data, results of photobiological tests, treatment parameters and clinical responses were collected from CAD patients who received NB-UVB phototherapy in Huashan Hospital affiliated to Fudan University from January 2008 to June 2015, and were reviewed retrospectively. Statistical analysis was done by using two independent samples t-test and chi-square test with SAS9.3 software to compare the clinical data between patients who completed and did not complete the NB-UVB phototherapy.ResultsA total of 79 CAD patients with Fitzpatrick skin type Ⅳ received NB-UVB phototherapy. Of these patients, 61 (77%) completed the whole treatment, while 18 (23%) dropped out because of intolerance to the NB-UVB radiation. Among the 61 patients who completed the treatment, the average initial, final and cumulative radiation doses of NB-UVB were (0.08 ± 0.01) J/cm2, (0.32 ± 0.08) J/cm2 and (5.9 ± 2.5) J respectively, and patients received (28 ± 8) times of treatment in average. When the radiation dose went up to 0.30 J/cm2, most skin lesions were cleared in 52 (85%) patients. A total of 19 patients received phototesting again after the end of phototherapy. Among 16 patients sensitive to ultraviolet A (UVA) before the treatment, 6 had normal minimal erythema dose to UVA (UVA-MED) , and another 6 had improved UVA-MED after the treatment. Among 16 patients sensitive to UVB before the treatment, 11 got normal UVB-MED and another 3 had improved UVB-MED after the treatment. Univariate analysis showed no significant differences in gender, age, duration of the disease, sensitivity to UVA and UVB radiation, results of photopatch test and patch test between the patients who completed and did not complete the treatment (all P > 0.05) .ConclusionsThe appropriate NB-UVB phototherapy for CAD patients should start at an initial radiation dose of 0.08 J/cm2 in spring and end at a final radiation dose of 0.30 J/cm2 for about 28 sessions, which can effectively reduce the photosensitivity to both UVA and UVB in CAD patients. Additionally, NB-UVB phototherapy can be applied in CAD patients of different gender, age, disease duration and photosensitive condition.Key words: Dermatitis, photoallergic; Ultraviolet therapy; Narrow-band ultraviolet ray; Phototest; Photopatch test" @default.
• W3029128861 created "2020-06-05" @default.
• W3029128861 creator A5020524854 @default.
• W3029128861 creator A5038475913 @default.
• W3029128861 creator A5062264436 @default.
• W3029128861 creator A5077309315 @default.
• W3029128861 date "2017-08-15" @default.
• W3029128861 modified "2023-09-26" @default.
• W3029128861 title "Narrow-band ultraviolet B phototherapy regimens for the treatment of chronic actinic dermatitis and analysis of factors influencing treatment compliance" @default.
• W3029128861 doi "https://doi.org/10.3760/cma.j.issn.0412-4030.2017.08.006" @default.
• W3029128861 hasPublicationYear "2017" @default.
• W3029128861 type Work @default.
• W3029128861 sameAs 3029128861 @default.
• W3029128861 citedByCount "0" @default.
• W3029128861 crossrefType "journal-article" @default.
• W3029128861 hasAuthorship W3029128861A5020524854 @default.
• W3029128861 hasAuthorship W3029128861A5038475913 @default.
• W3029128861 hasAuthorship W3029128861A5062264436 @default.
• W3029128861 hasAuthorship W3029128861A5077309315 @default.
• W3029128861 hasConcept C126322002 @default.
• W3029128861 hasConcept C126894567 @default.
• W3029128861 hasConcept C138944611 @default.
• W3029128861 hasConcept C151032500 @default.
• W3029128861 hasConcept C16005928 @default.
• W3029128861 hasConcept C2779121184 @default.
• W3029128861 hasConcept C3018082644 @default.
• W3029128861 hasConcept C71924100 @default.
• W3029128861 hasConceptScore W3029128861C126322002 @default.
• W3029128861 hasConceptScore W3029128861C126894567 @default.
• W3029128861 hasConceptScore W3029128861C138944611 @default.
• W3029128861 hasConceptScore W3029128861C151032500 @default.
• W3029128861 hasConceptScore W3029128861C16005928 @default.
• W3029128861 hasConceptScore W3029128861C2779121184 @default.
• W3029128861 hasConceptScore W3029128861C3018082644 @default.
• W3029128861 hasConceptScore W3029128861C71924100 @default.
• W3029128861 hasIssue "8" @default.
• W3029128861 hasLocation W30291288611 @default.
• W3029128861 hasOpenAccess W3029128861 @default.
• W3029128861 hasPrimaryLocation W30291288611 @default.
• W3029128861 hasRelatedWork W1703946182 @default.
• W3029128861 hasRelatedWork W1885902174 @default.
• W3029128861 hasRelatedWork W1982601831 @default.
• W3029128861 hasRelatedWork W2014577504 @default.
• W3029128861 hasRelatedWork W2027363662 @default.
• W3029128861 hasRelatedWork W2048432863 @default.
• W3029128861 hasRelatedWork W2113118704 @default.
• W3029128861 hasRelatedWork W2142653395 @default.
• W3029128861 hasRelatedWork W2160849202 @default.
• W3029128861 hasRelatedWork W2185264244 @default.
• W3029128861 hasRelatedWork W2341815245 @default.
• W3029128861 hasRelatedWork W2528205641 @default.
• W3029128861 hasRelatedWork W2626795542 @default.
• W3029128861 hasRelatedWork W2736039522 @default.
• W3029128861 hasRelatedWork W2766197363 @default.
• W3029128861 hasRelatedWork W2809267299 @default.
• W3029128861 hasRelatedWork W2905561991 @default.
• W3029128861 hasRelatedWork W2989016146 @default.
• W3029128861 hasRelatedWork W34974504 @default.
• W3029128861 hasRelatedWork W6686152 @default.
• W3029128861 hasVolume "50" @default.
• W3029128861 isParatext "false" @default.
• W3029128861 isRetracted "false" @default.
• W3029128861 magId "3029128861" @default.
• W3029128861 workType "article" @default.